Case Report
Uterine Scar Dehiscence Found During Emergency Caesarean Section: A Case Report
Emiliana Dismas Mvungi*,
Innocent Lutakyamilwa Kaiza,
Ndakibae Gabriel Mabega
Issue:
Volume 14, Issue 3, June 2026
Pages:
71-74
Received:
14 May 2026
Accepted:
28 May 2026
Published:
12 June 2026
Abstract: Background: We are presenting a 27 years old female with her second pregnancy at 42 weeks of gestation who was admitted because she was post date with one previous uterine scar and planned for emergency caesarean section due to aforementioned reasons. She was prepared and sent to theatre where uterine scar dehiscence was found but she got a live fetus male baby weighed 3.2kg and scored 9 and 10 at 1st and 5th minutes respectively. The patient received all necessary post operative cares, she progress well while in the ward and was discharged in good health after 3 days and came again in the 7th day for suture remove and then continued with post natal visits as per protocol until was discharged from the clinic. Conclusion: Uterine scar dehiscence without notable complications to the mother and her fetus is rare condition which necessitates serious attention to most women with previous caesarean delivery. In preconception period around 3 to 6 months post previous c/section, transvaginal ultrasound is ideal to measure the lower uterine segment thickness and during pregnancy is better at 32 to 36 weeks using trans-abdominal ultrasound. Whenever an ultrasound is not conclusive, MRI can be used. This case is presented to emphasize on importance of scheduled caesarean section at 37 completed weeks.
Abstract: Background: We are presenting a 27 years old female with her second pregnancy at 42 weeks of gestation who was admitted because she was post date with one previous uterine scar and planned for emergency caesarean section due to aforementioned reasons. She was prepared and sent to theatre where uterine scar dehiscence was found but she got a live fe...
Show More
Research Article
Exploring on the Hyperinsulinism Management in Women with Polycystic Ovary Syndrome
Issue:
Volume 14, Issue 3, June 2026
Pages:
75-85
Received:
19 February 2026
Accepted:
18 March 2026
Published:
11 July 2026
DOI:
10.11648/j.jgo.20261403.12
Downloads:
Views:
Abstract: This comprehensive review focuses on the relevance of hyperinsulinemia in women with polycystic ovary syndrome (PCOS). It highlights the most robust scientific evidence on the management of this condition within the context of PCOS. A systematic search of studies published in English language was conducted using Google Scholar, PubMed, and Cochrane databases. Keywords used alone or combined with “PCOS” included: hyperinsulinemia, incretin hormones, and dipeptidyl peptidase-4. The search strategy was complemented by manual review of references from selected articles. Glucagon-like peptide-1 receptor agonist and glucagon-dependent insulin tropic polypeptide provide various metabolic beneficial effects in addition to the weight loss. Dipeptidyl peptidase-4 inhibitors, expressed by various cells, prevent GLP-1 degradation and decreases insulin signaling in different cells, particularly in hepatocytes, and adipocytes. Regarding the management of hyperinsulinemia, the review suggests that incretin hormone agonist and dipeptidyl peptidase-4 inhibitors may represent favorable therapeutic options for addressing insulin resistance in women with PCOS, particularly those with obesity. However, this review does not explore dietary interventions and physical activity as primary strategies for managing dysglycemia in this population.
Abstract: This comprehensive review focuses on the relevance of hyperinsulinemia in women with polycystic ovary syndrome (PCOS). It highlights the most robust scientific evidence on the management of this condition within the context of PCOS. A systematic search of studies published in English language was conducted using Google Scholar, PubMed, and Cochrane...
Show More
